13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 54 holding rows worth $400,578,967.
- Accession
- 0001420506-25-000514
- Filer
- CIK 1952142
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 58 entries on the cover page, a total value of $400,578,967 stated on the cover page (in dollars after the unit check, H1), rows summing to $400,578,967 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,872,601 | $37,975,785 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,712,778 | $32,092,164 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,118,508 | $27,705,443 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 614,812 | $25,852,845 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 317,060 | $16,211,278 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 375,845 | $14,733,124 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 193,623 | $13,373,541 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 416,968 | $11,992,000 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 584,328 | $11,908,605 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 208,016 | $11,644,736 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 145,234 | $11,368,918 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 641,964 | $10,752,897 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 134,178 | $10,326,339 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 166,068 | $9,392,806 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 721,209 | $8,921,355 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 193,535 | $8,465,221 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 992,803 | $8,409,041 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 145,876 | $7,810,201 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 106,610 | $7,360,354 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 166,307 | $7,187,789 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 949,401 | $7,025,567 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 61,403 | $6,996,872 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 500,966 | $6,978,456 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 186,413 | $6,962,526 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 2,328,492 | $5,946,790 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 141,714 | $5,470,160 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 1,704,825 | $5,353,151 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 350,573 | $5,030,723 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 400,101 | $4,925,243 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 428,137 | $4,538,252 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 579,500 | $4,317,275 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 101,809 | $4,283,105 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 545,800 | $4,268,156 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 83,576 | $3,931,415 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 265,833 | $3,894,453 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 132,706 | $3,543,250 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 270,983 | $3,406,256 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 135,244 | $2,891,517 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 126,400 | $2,563,392 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 96,716 | $2,176,110 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 200,900 | $2,109,450 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 332,394 | $1,755,040 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 90,000 | $1,589,400 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 150,000 | $1,527,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 28,136 | $1,306,636 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 47,642 | $1,280,617 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 200,475 | $725,720 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,575,000 | $580,625 | dollars as filed | call |
| INVESCO QQQ TR | 46090E103 | COM | 70,000 | $514,500 | dollars as filed | put |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 9,434 | $435,568 | dollars as filed | |
| SPY | 78462F103 | SHS | 85,000 | $413,775 | dollars as filed | put |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 100,000 | $227,500 | dollars as filed | call |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 75,000 | $75,000 | dollars as filed | call |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 234,100 | $51,025 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-000514 | this filing | 2025-02-14 | acceptance time not in the bulk data set |